Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib

Hematol Oncol. 2015 Dec;33(4):250-2. doi: 10.1002/hon.2156. Epub 2014 Sep 25.

¹ Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. [email protected].
² Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
³ Laboratory of Clinical Pathology, Section of Flow Cytometry, Versilia Hospital, Lido di Camaiore, Italy.
⁴ Division of Pharmacology, Department of Clinical and Experimental Medicine,University of Pisa, Pisa, Italy.
⁵ Laboratory of Cytogenetics, AOUP, University of Pisa, Pisa, Italy.

No abstract available

Publication types